Literature DB >> 20096700

Generation of monoclonal antibodies against human regulatory T cells.

Christian Becker1, Heinz Hoschützky, Wolfgang Rist, Martin Lenter, Franz-Joseph Schneider, Helmut Jonuleit.   

Abstract

Natural CD4(+)CD25(+)Foxp3(+) regulatory T cells (Tregs) control the activation of the immune system and therefore have become a major area of research in immunology. The generation of monoclonal antibodies against human Tregs offers the possibility to discover novel Treg-specific or Treg-associated surface markers and to identify targets for a therapeutic modulation of Tregs. Here we present a methodology optimized to efficiently induce and select mAb against human Tregs by repeated immunization of mice with Tregs from a single donor and a differential two-step flow cytometry-based hybridoma screening procedure. 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20096700     DOI: 10.1016/j.jim.2010.01.002

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  2 in total

1.  Establishment of a monoclonal antibody against a peptide of the novel zinc finger protein ZNF32 proved to be specific and sensitive for immunological measurements.

Authors:  Yuyan Wei; Jie Zhang; Kai Li; Lugang Huang; Jun Li; Xiujie Wang; Ping Lin; Yuquan Wei
Journal:  Med Sci Monit       Date:  2012-05

2.  Phenotypic screening reveals TNFR2 as a promising target for cancer immunotherapy.

Authors:  Geoffrey S Williams; Bina Mistry; Sandrine Guillard; Jane Coates Ulrichsen; Alan M Sandercock; Jun Wang; Andrea González-Muñoz; Julie Parmentier; Chelsea Black; Jo Soden; Jim Freeth; Jelena Jovanović; Rebecca Leyland; Rafia S Al-Lamki; Andrew J Leishman; Steven J Rust; Ross Stewart; Lutz Jermutus; John R Bradley; Vahe Bedian; Viia Valge-Archer; Ralph Minter; Robert W Wilkinson
Journal:  Oncotarget       Date:  2016-10-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.